Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Gallimore

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1983
Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical materialN Egberg, M J Gallimore
Thrombosis and Haemostasis|December 29, 1984
Prekallikrein activatorM J Gallimore, P Friberger
Advances in Experimental Medicine and Biology|January 1, 1983
Studies on components of the plasma kallikrein and complement systems in plasma and serum samples from normal individuals and patients with hereditary angioedemaM J Gallimore, A M Ward
Thrombosis Research|March 1, 1978
The purification of a human plasma kallikrein with weak plasminogen activator activityM J Gallimore, E Fareid, H Stormorken
Thrombosis and Haemostasis|April 1, 1996
Pseudo factor XII deficiency and phospholipid antibodiesD W Jones, M J Gallimore, M Winter
Fertility and Sterility|December 4, 2001
Recurrent abortion-antibodies to factor XII or a decrease in factor XII levels?D W Jones, M J Gallimore, M Winter
Thrombosis Research|June 1, 1994
Aprotinin in therapeutic doses inhibits chromogenic peptide substrate assays for protein CH P Wendel, W Heller, M J Gallimore
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
An automated chromogenic peptide substrate assay for coagulation factor XIID W Jones, M J Gallimore, M Winter
Agents and Actions. Supplements|January 1, 1992
Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypassW Heller, M J Gallimore, H E Hoffmeister
Haemostasis|January 1, 1978
Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogsM J Gallimore, A O Aasen, E Amundsen
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|January 1, 1983
Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical materialN Egberg, M J Gallimore
Thrombosis and Haemostasis|December 29, 1984
Prekallikrein activatorM J Gallimore, P Friberger
Advances in Experimental Medicine and Biology|January 1, 1983
Studies on components of the plasma kallikrein and complement systems in plasma and serum samples from normal individuals and patients with hereditary angioedemaM J Gallimore, A M Ward
Thrombosis Research|March 1, 1978
The purification of a human plasma kallikrein with weak plasminogen activator activityM J Gallimore, E Fareid, H Stormorken
Thrombosis and Haemostasis|April 1, 1996
Pseudo factor XII deficiency and phospholipid antibodiesD W Jones, M J Gallimore, M Winter
Fertility and Sterility|December 4, 2001
Recurrent abortion-antibodies to factor XII or a decrease in factor XII levels?D W Jones, M J Gallimore, M Winter
Thrombosis Research|June 1, 1994
Aprotinin in therapeutic doses inhibits chromogenic peptide substrate assays for protein CH P Wendel, W Heller, M J Gallimore
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
An automated chromogenic peptide substrate assay for coagulation factor XIID W Jones, M J Gallimore, M Winter
Agents and Actions. Supplements|January 1, 1992
Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypassW Heller, M J Gallimore, H E Hoffmeister
Haemostasis|January 1, 1978
Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogsM J Gallimore, A O Aasen, E Amundsen
Pageof 7